Stercobilin is an end-stage metabolite of hemoglobin, a component of red blood cells. It has been found that there is a significantly lower concentration of stercobilin in the urine of people diagnosed with autism spectrum disorders, suggesting potential use as a biomarker. In vitro, we have synthesized stercobilin from its precursor bilirubin through a reduction reaction proceeded by an oxidation reaction. In addition, we have isotopically labeled the stercobilin product with deuterium using this protocol. Nuclear magnetic resonance investigations show the products of the unlabeled stercobilin (Rxn 1) and the deuterated stercobilin (Rxn 2) both had a loss of signals in the 5.0- to 7.0-ppm range indicating proper conversion to stercobilin. Changes in the multiplicity of the sp3 region of the proton nuclear magnetic resonance suggest proper deuterium incorporation. Mass spectrometry studies of Rxn 1 show a difference in fragmentation patterns than that of Rxn 2 proposing potential locations for deuterium incorporation. This isotopologue of stercobilin is stable (>6 mo), and further analysis permits investigation for its use as a biomarker and potential quantitative diagnostic probe for autism spectrum disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jlcr.3629DOI Listing

Publication Analysis

Top Keywords

stercobilin
9
labeled stercobilin
8
potential biomarker
8
autism spectrum
8
spectrum disorders
8
nuclear magnetic
8
magnetic resonance
8
stercobilin rxn
8
deuterium incorporation
8
synthesis characterization
4

Similar Publications

Integrated metabolomic and microbiome analysis identifies Cupriavidus metallidurans as a potential therapeutic target for β-thalassemia.

Ann Hematol

October 2024

Department of Hematology, The Second Xiangya Hospital, Molecular Biology Research Center, Center for Medical Genetics, School of Life Sciences, Hunan Province Key Laboratory of Basic and Applied Hematology, Central South University, Changsha, 410011, China.

Article Synopsis
  • - β-thalassemia (β-TH) is a genetic blood disorder causing issues like anemia and iron overload, primarily found in certain tropical and subtropical areas, with its link to gut microbiota and metabolites not fully understood.
  • - A study using Th3/+ mice, a model for β-thalassemia intermedia, compared fecal metabolomics and metagenomics, revealing increased bilirubin metabolism and changes in gut bacteria.
  • - The research identified Cupriavidus metallidurans as a beneficial bacterium that helps reduce anemia by lowering iron levels in the liver and spleen, marking a new approach to managing β-TH through gut microbiota modification.
View Article and Find Full Text PDF

Objectives: Fecal immunochemical tests (FIT) for hemoglobin are currently considered the screening investigation of choice for colorectal cancer and are worldwide recommended. Similarly, fecal calprotectin is a widely used test for monitoring intestinal inflammation. The pre-analytical issues regarding stool samples have hardly been dealt with and are difficult to solve.

View Article and Find Full Text PDF

Background: Hepatic encephalopathy (HE) is a neurological disorder resulting from advanced liver injury. HE has a high mortality rate and poor prognosis. The pathogenesis of HE is still unclear, which has led to the lack of a satisfactory specific treatment method.

View Article and Find Full Text PDF

Discovery of Unprecedented Human Stercobilin Conjugates.

Drug Metab Dispos

August 2024

Department of Drug Metabolism and Pharmacokinetics (S.C., L.C., J.C., L.S., D.Z., S.C.K.) Genentech, Inc., South San Francisco, California; and Hypha Discovery (S.K.W., R.T.G., T.K., J.C.P.S.), Oxfordshire, United Kingdom.

Article Synopsis
  • - Two new metabolites (M18 and M19) derived from the drug inavolisib were found in the feces of human volunteers, indicating a significant alteration of the drug's structure after oral administration.
  • - These metabolites were produced through reactions with stercobilin, a compound made by gut bacteria when breaking down heme, and involved both chemical and potentially enzymatic processes.
  • - The study suggests a new mechanism for the formation of these metabolites and highlights their unique characteristics, potentially shedding light on similar drug interactions that may have been missed in earlier research.
View Article and Find Full Text PDF

Introduction: The branched-chain amino acids (BCAAs) are essential to mammalian growth and development but aberrantly elevated in obesity and diabetes. Each BCAA has an independent and specific physio-biochemical effect on the host. However, the exact molecular mechanism of the detrimental effect of valine on metabolic health remains largely unknown.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!